Recent Studies from Abbott Laboratories Add New Data to COVID-19 (Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassay).

Předmět:	SARS-CoV-2 COVID-19 IMMUNOASSAY MEDICAL journalism
Zdroj:	NewsRx COVID-19 Weekly; 3/10/2023, p445-445, 1p
Abstrakt:	Keywords: Abbott Laboratories; COVID-19; Coronavirus; Health and Medicine; Healthcare Companies; Immunoassay; Pharmaceutical Companies; RNA Viruses; SARS-CoV-2; Severe Acute Respiratory Syndrome Coronavirus 2; Viral; Virology EN Abbott Laboratories COVID-19 Coronavirus Health and Medicine Healthcare Companies Immunoassay Pharmaceutical Companies RNA Viruses SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 Viral Virology 2023 MAR 12 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx COVID-19 Weekly -- Researchers detail new data in COVID-19. According to the news editors, the research concluded: "The prototype SARS-CoV-2 antigen ARCHITECT immunoassay is sensitive and specific for detection of SARS-CoV-2 in nasal and nasopharyngeal specimens. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu